NASDAQ : SIGA
SIGA Technologies, Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 3.04 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 218.42M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 218.42M |
| Enterprise Value | 101.28M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | Apr 7, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 71.85M |
| Shares Outstanding | 71.85M |
| Shares Change (YoY) | -0.30% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 9.13% |
| Owned by Institutions (%) | 49.66% |
| Float | 41.11M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 60.80 |
| PS Ratio | 4.07 |
| Forward PS | n/a |
| PB Ratio | 1.32 |
| P/TBV Ratio | 1.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 21.72 |
| Quick Ratio | 15.90 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -1.49% |
| Return on Assets (ROA) | -3.39% |
| Return on Invested Capital (ROIC) | -23.13% |
| Return on Capital Employed (ROCE) | -6.63% |
| Weighted Average Cost of Capital (WACC) | 9.52% |
| Revenue Per Employee | $1.10M |
| Profits Per Employee | -$56,868 |
| Employee Count | 49 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 1.17 |
Taxes
| Measure | Value |
|---|
| Income Tax | -2.72M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -62.61% |
| 50-Day Moving Average | 3.19 |
| 200-Day Moving Average | 4.38 |
| Relative Strength Index (RSI) | 41.36 |
| Average Volume (20 Days) | 505,408 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.56M |
| Short Previous Month | 3.60M |
| Short % of Shares Out | 4.96% |
| Short % of Float | 8.67% |
| Short Ratio (days to cover) | 5.68 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 53.66M |
| Gross Profit | 8.73M |
| Operating Income | -11.14M |
| Pretax Income | -5.51M |
| Net Income | -2.79M |
| EBITDA | -10.55M |
| EBIT | -11.14M |
| Loss Per Share | -$0.04 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 117.58M |
| Total Debt | 439,397 |
| Net Cash | 117.15M |
| Net Cash Per Share | $1.63 |
| Equity (Book Value) | 165.29M |
| Book Value Per Share | 2.30 |
| Working Capital | 162.53M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -20.17M |
| Capital Expenditures | -330,115 |
| Depreciation & Amortization | 590,481 |
| Net Borrowing | n/a |
| Free Cash Flow | -20.50M |
| FCF Per Share | -$0.29 |
Margins
| Measure | Value |
|---|
| Gross Margin | 16.28% |
| Operating Margin | -20.76% |
| Pretax Margin | -10.27% |
| Profit Margin | -5.19% |
| EBITDA Margin | -19.66% |
| EBIT Margin | -20.76% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.60 |
| Dividend Yield | 19.74% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.30% |
| Shareholder Yield | 20.04% |
| Earnings Yield | -1.28% |
| FCF Yield | -9.38% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 27.21 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |